(b)(4).Title radiofrequency ablation of stage ia non-small cell lung cancer in medically inoperable patients: results from the american college of surgeons oncology group z4033 (alliance) trial.Source cancer, volume 121, 2015(1-23) article number: 19 date of publication: 1 october 2015.If information is provided in the future, a supplemental report will be issued.
|
According to the literature study performed last december 2006 to november 2010, in a study evaluated the two-year overall survival (os), adverse event rate, local control rate and impact on pulmonary function tests (pfts) in medically inoperable patients with stage ia nsclc (non-small cell lung cancer) undergoing ct-guided rfa (radiofrequency ablation) in a prospective multi-center trial.54 patients m:f=25:29, median age/range= 76/60-89 were enrolled from 16 us centers 51 patients were eligible (biopsy proven stage ia nsclc and deemed medically inoperable by board certified thoracic surgeon) for evaluation.Pfts were obtained within 60 days of rfa, 3 and 24 months after rfa.All patients were treated with a covidien cluster cool-tip electrode (covidien, (b)(4)) under ct-guidance according to the manufacturer¿s specifications.Out of 54 patients, 1 had pleural effusion requiring drainage and 1 pulmonary infection.
|